Dominika Golubczyk1, Izabela Malysz-Cymborska1, Lukasz Kalkowski1, Michal Zawadzki2, Piotr Holak3, Joanna Glodek3, Kamila Milewska1, Marek Bogacki4, Mirosław Janowski5,6,7, Zbigniew Adamiak3, Wojciech Maksymowicz1, and Piotr Walczak1,6,7
1Department of Neurology and Neurosurgery, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland, 2Central Clinical Hospital of Ministry of the Interior and Administration in Warsaw, Warsaw, Poland, 3Department of Surgery and Roentgenology with the Clinic, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland, 4Department of Gamete and Embryo Biology, Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, Olsztyn, Poland, 5NeuroRepair Department, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland, 6Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 7Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Synopsis
Animal models of stroke are essential for
developing therapies. Rodent models of stroke are widely used but they lack
clinical relevance. Endovascular models in large animals are most desired, but
till now they were available in expensive and hard-to-access dogs and primates.
Swine is preferred model but till now stroke modeling was through surgical craniotomy,
a highly invasive procedure inflicting unrelated morbidity. Endovascular
modeling was not possible due to vascular rete
preventing catheter access to cerebral vessels. We circumvented this obstacle by
intra-arterially injecting SPIO-labeled pro-coagulant thrombin under real-time
MRI, which was instrumental to fine-tune injection to occlude cerebral
arteries.
Introduction
Stroke is a leading cause of serious, long-term
disability.1 Rodent
models play an important role in studying stroke and developing therapies;
however, relying solely on rodents proved inadequate as practically all
clinical trials, that were based on rodent data only, failed. STAIR2
and STEPS3 recommend
testing experimental therapies of stroke in large, gyrencephalic animals prior
to first-in-man studies. The endovascular approach accurately mimics clinical
stroke, but until now it was available in expensive and hard to access species
such as dogs and primates. The swine is a low-cost and easily available
laboratory large animal, but the rete, a
network of microvessels separating extracranial and intracranial circulation (Fig. 2A,B), precluded advancing
intra-arterial catheter into cerebral vessels for local obstruction of
cerebral blood flow. Therefore, the stroke was till now induced in pigs through
highly invasive and complex surgery including craniotomy and clipping or
coagulating cerebral vessels4. To
address this challenge we took an advantage of our previously established
interventional MRI approaches, which were proved to be excellent for monitoring
intra-arterial targeting.5 We
explored utility of these techniques for inducing endovascular model of
cerebral ischemia in pig.
We used minimally
invasive, catheter-based endovascular technique for catheter navigation under
X-ray followed by MRI to guide occlusion of cerebral vessels. Real-time MRI allowed
immediate visualization and continuous feedback, which were instrumental for
precise administration of intraarterial thrombin until the obstruction of
cerebral blood flow has been verified by contrast-enhanced DSC perfusion
imaging.
Methods
Overall experimental design is shown in Fig.1. The animal procedures were
approved by local ethics committee and were performed according to ARRIVE
guidelines. Juvenile, male, domestic pigs were anesthetized by propofol (3-5mg/kg/h
i.v.) and sevoflurane (1 – 2,5 %). Introducer (5F, Prelude MeritMedical) was inserted into femoral
artery after percutaneous puncture. Using this port, guiding catheter was
navigated under C-arm guidance to common carotid artery (CCA) followed by
microcatheter (APOLLO™ Medtronic) with
its tip positioned in ascending pharyngeal artery (APA) proximally to the rete mirabile (Fig.2B). Continuous flow of heparinized saline was maintained in
guiding catheter and microcatheter to avoid thrombotic occlusion. Animals with secured
microcatheters were transferred to 3T MRI scanner (Magnetom Trio, Siemens). Under
real time MRI guidance thrombin solution (Biomed, Poland) mixed with feraheme
(1:20) was injected intra-arterially as two boluses (80 Units and 320 Units
respectively) with 20 minutes interspace. MRI protocol included dynamic GE-EPI
for assessment of trans-catheter cerebral perfusion, GE-EPI for monitoring
thrombin-mediated blood clotting as well as SWI, diffusion, T2w and T1w with
contrast. MRI follow up was performed one day, two days and one month post stroke
induction. Images were analyzed using AMIRA6.4 (Thermo Fisher Scientific – FEI). Results
Baseline feraheme-enhanced perfusion MR scans showed
brain territory supplied by the catheter infusion (3D reconstruction of
perfused area is shown in Fig.3A,
rapid clearance of the contrast shown in graph 3A’). Thrombin injection visualized in real-time on dynamic GE-EPI
scans resulted in only minor vascular blockage after first bolus but second
infusion was effective with extensive retention of hypointensity shown as 3D
reconstruction Fig.3B and
dynamically quantified in Fig.3B’. SWI scan confirmed retention of
hypointensities indicating vascular blockage (Fig.3D). Perfusion was visibly smaller after thrombin as shown with
another feraheme-enhanced perfusion scan (8,754.4 mm3 before thrombin and 6,484.59 mm3 after clot
formation; Fig.3C).
Notably, there was dramatic difference in clearance of feraheme with rapid clearance at baseline lasting ~18 sec (Fig.3A’) and sluggish clearance after thrombin ~250 sec (Fig.3C`). Diffusion
weighted MRI detected first evidence of ischemic damage 27 minutes post
thrombin as hypointense region on ADC map (Fig.4C),
with subsequent intensification of pathological signal. T2w scan 17 hours post
stroke induction confirmed ischemia (Fig.5H).
Assessment of BBB status with T1+Gd showed no enhancement over initial 17 hours
and disruption was observed in the infarcted cortex 36 hours after procedure (Fig.5N). One-month follow-up revealed BBB
opening within white matter (Fig.5O).
Lesion resulted in marked neurological deficits in contralateral limbs
primarily manifested as severe hind limb paresis, however the animal was
ambulatory and did not required an intensive care. Conclusion
Our study has demonstrated feasibility of using
endovascular route to induce ischemic stroke in pig. Most importantly,
real-time MRI was instrumental to monitor and confirm formation of
thrombin-induced clot and resulting blockade of cerebral perfusion with
subsequent brain infarct. Our method produced
cerebral ischemia in relatively large volume, which covers majority of MCA supply
territory. Overall, we have established a new model of ischemic stroke in pigs characterized
by high clinical relevance.Acknowledgements
Funding: NCBIR EXPLOREME
grant (STRATEGMED1/235773/19/NCBR/2016)References
1 Writing Group, M.
et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the
American Heart Association. Circulation
133, e38-360,
doi:10.1161/CIR.0000000000000350 (2016).
2 Fisher, M. et al.
Update of the stroke therapy academic industry roundtable preclinical
recommendations. Stroke 40, 2244-2250,
doi:10.1161/STROKEAHA.108.541128 (2009).
3 Savitz, S. I. et
al. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 42, 825-829, doi:10.1161/STROKEAHA.110.601914 (2011).
4 Arikan, F. et al.
Malignant infarction of the middle cerebral artery in a porcine model. A pilot
study. PLoS One 12, e0172637, doi:10.1371/journal.pone.0172637 (2017).
5 Janowski, M., Walczak, P. & Pearl, M. S. Predicting
and optimizing the territory of blood-brain barrier opening by superselective
intra-arterial cerebral infusion under dynamic susceptibility contrast MRI guidance. J Cereb Blood Flow Metab 36, 569-575, doi:10.1177/0271678X15615875 (2016).